Home > Research > Publications & Outputs > The R package MAMS for designing multi-arm mult...

Electronic data

  • JSS2434

    Accepted author manuscript, 389 KB, PDF document

    Available under license: CC BY-NC: Creative Commons Attribution-NonCommercial 4.0 International License

Links

Text available via DOI:

View graph of relations

The R package MAMS for designing multi-arm multi-stage clinical trials

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Published

Standard

The R package MAMS for designing multi-arm multi-stage clinical trials. / Jaki, Thomas Friedrich; Pallmann, Philip Steffen; Magirr, Dominic.
In: Journal of Statistical Software, Vol. 88, No. 4, 31.01.2019.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Harvard

APA

Vancouver

Jaki TF, Pallmann PS, Magirr D. The R package MAMS for designing multi-arm multi-stage clinical trials. Journal of Statistical Software. 2019 Jan 31;88(4). doi: 10.18637/jss.v088.i04

Author

Jaki, Thomas Friedrich ; Pallmann, Philip Steffen ; Magirr, Dominic. / The R package MAMS for designing multi-arm multi-stage clinical trials. In: Journal of Statistical Software. 2019 ; Vol. 88, No. 4.

Bibtex

@article{2d215af6890f4d8cb28f6874b274dd68,
title = "The R package MAMS for designing multi-arm multi-stage clinical trials",
abstract = "In the early stages of drug development there is often uncertainty about the most promising among a set of different treatments, different doses of the same treatment, or combinations of treatments. Multi-arm multi-stage (MAMS) clinical studies provide an efficient solution to determine which intervention is most promising. In this paper we discuss the R package MAMS that allows designing such studies within the group-sequential framework. The package implements MAMS studies with normal, binary, ordinal, or timeto-event endpoints in which either the single best treatment or all promising treatments are continued at the interim analyses. Additionally unexpected design modifications can be accounted for via the use of the conditional error approach. We provide illustrative examples of the use of the package based on real trial designs.",
keywords = "adaptive designs, conditional error, multi-arm, R, step-down procedure",
author = "Jaki, {Thomas Friedrich} and Pallmann, {Philip Steffen} and Dominic Magirr",
year = "2019",
month = jan,
day = "31",
doi = "10.18637/jss.v088.i04",
language = "English",
volume = "88",
journal = "Journal of Statistical Software",
issn = "1548-7660",
publisher = "University of California at Los Angeles",
number = "4",

}

RIS

TY - JOUR

T1 - The R package MAMS for designing multi-arm multi-stage clinical trials

AU - Jaki, Thomas Friedrich

AU - Pallmann, Philip Steffen

AU - Magirr, Dominic

PY - 2019/1/31

Y1 - 2019/1/31

N2 - In the early stages of drug development there is often uncertainty about the most promising among a set of different treatments, different doses of the same treatment, or combinations of treatments. Multi-arm multi-stage (MAMS) clinical studies provide an efficient solution to determine which intervention is most promising. In this paper we discuss the R package MAMS that allows designing such studies within the group-sequential framework. The package implements MAMS studies with normal, binary, ordinal, or timeto-event endpoints in which either the single best treatment or all promising treatments are continued at the interim analyses. Additionally unexpected design modifications can be accounted for via the use of the conditional error approach. We provide illustrative examples of the use of the package based on real trial designs.

AB - In the early stages of drug development there is often uncertainty about the most promising among a set of different treatments, different doses of the same treatment, or combinations of treatments. Multi-arm multi-stage (MAMS) clinical studies provide an efficient solution to determine which intervention is most promising. In this paper we discuss the R package MAMS that allows designing such studies within the group-sequential framework. The package implements MAMS studies with normal, binary, ordinal, or timeto-event endpoints in which either the single best treatment or all promising treatments are continued at the interim analyses. Additionally unexpected design modifications can be accounted for via the use of the conditional error approach. We provide illustrative examples of the use of the package based on real trial designs.

KW - adaptive designs

KW - conditional error

KW - multi-arm

KW - R

KW - step-down procedure

U2 - 10.18637/jss.v088.i04

DO - 10.18637/jss.v088.i04

M3 - Journal article

VL - 88

JO - Journal of Statistical Software

JF - Journal of Statistical Software

SN - 1548-7660

IS - 4

ER -